123 related articles for article (PubMed ID: 38204676)
1. Discussion to: Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome.
JTCVS Open; 2023 Dec; 16():673-674. PubMed ID: 38204676
[No Abstract] [Full Text] [Related]
2. Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome.
Wittenberg RE; Gauvreau K; Leighton J; Moleon-Shea M; Borow KM; Marx GR; Emani SM
JTCVS Open; 2023 Dec; 16():656-672. PubMed ID: 38204673
[TBL] [Abstract][Full Text] [Related]
3. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
Kaushal S; Wehman B; Pietris N; Naughton C; Bentzen SM; Bigham G; Mishra R; Sharma S; Vricella L; Everett AD; Deatrick KB; Huang S; Mehta H; Ravekes WA; Hibino N; Difede DL; Khan A; Hare JM
Am Heart J; 2017 Oct; 192():48-56. PubMed ID: 28938963
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections.
Burkhart HM; Qureshi MY; Rossano JW; Cantero Peral S; O'Leary PW; Hathcock M; Kremers W; Nelson TJ;
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1614-1623. PubMed ID: 31345560
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
6. Hypoplastic left heart syndrome: consensus and controversies in 2007.
Wernovsky G; Ghanayem N; Ohye RG; Bacha EA; Jacobs JP; Gaynor JW; Tabbutt S
Cardiol Young; 2007 Sep; 17 Suppl 2():75-86. PubMed ID: 18039401
[TBL] [Abstract][Full Text] [Related]
7. Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study).
Kaushal S; Hare JM; Shah AM; Pietris NP; Bettencourt JL; Piller LB; Khan A; Snyder A; Boyd RM; Abdullah M; Mishra R; Sharma S; Slesnick TC; Si MS; Chai PJ; Davis BR; Lai D; Davis ME; Mahle WT
Pediatr Cardiol; 2022 Oct; 43(7):1481-1493. PubMed ID: 35394149
[TBL] [Abstract][Full Text] [Related]
8. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.
Tarui S; Ishigami S; Ousaka D; Kasahara S; Ohtsuki S; Sano S; Oh H
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1198-1207, 1208.e1-2. PubMed ID: 26232942
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Feeding Strategies for Infants With Hypoplastic Left Heart Syndrome: A Randomized Controlled Trial.
Spillane NT; Kashyap S; Bateman D; Weindler M; Krishnamurthy G
World J Pediatr Congenit Heart Surg; 2016 Jul; 7(4):446-53. PubMed ID: 27358299
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions.
Bittle GJ; Morales D; Deatrick KB; Parchment N; Saha P; Mishra R; Sharma S; Pietris N; Vasilenko A; Bor C; Ambastha C; Gunasekaran M; Li D; Kaushal S
Circ Res; 2018 Jul; 123(2):288-300. PubMed ID: 29976693
[TBL] [Abstract][Full Text] [Related]
11. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
Borow KM; Yaroshinsky A; Greenberg B; Perin EC
Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
[TBL] [Abstract][Full Text] [Related]
12. Safety and feasibility of adjunct autologous cord blood stem cell therapy during the Norwood heart operation.
Brizard CP; Elwood NJ; Kowalski R; Horton SB; Jones BO; Hutchinson D; Zannino D; Sheridan BJ; Butt W; Cheung MMH; Pepe S
J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1746-1755. PubMed ID: 37527726
[TBL] [Abstract][Full Text] [Related]
13. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
[TBL] [Abstract][Full Text] [Related]
14. Perception scores of siblings and parents of children with hypoplastic left heart syndrome.
Caris EC; Dempster N; Wernovsky G; Miao Y; Moore-Clingenpeel M; Neely T; Fonseca R; Miller-Tate H; Allen R; Fichtner S; Stewart J; Cua CL
Congenit Heart Dis; 2018 Jul; 13(4):528-532. PubMed ID: 30019479
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.
Ascheim DD; Gelijns AC; Goldstein D; Moye LA; Smedira N; Lee S; Klodell CT; Szady A; Parides MK; Jeffries NO; Skerrett D; Taylor DA; Rame JE; Milano C; Rogers JG; Lynch J; Dewey T; Eichhorn E; Sun B; Feldman D; Simari R; O'Gara PT; Taddei-Peters WC; Miller MA; Naka Y; Bagiella E; Rose EA; Woo YJ
Circulation; 2014 Jun; 129(22):2287-96. PubMed ID: 24682346
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.
Nägele F; Pölzl L; Graber M; Hirsch J; Mayr A; Pamminger M; Troger F; Theurl M; Schreinlechner M; Sappler N; Dorfmüller C; Mitrovic M; Ulmer H; Grimm M; Gollmann-Tepeköylü C; Holfeld J
Trials; 2022 Dec; 23(1):988. PubMed ID: 36494706
[TBL] [Abstract][Full Text] [Related]
17. Automated echocardiographic analysis of systemic ventricular performance in hypoplastic left heart syndrome.
Kimball TR; Witt SA; Khoury PR; Daniels SR
J Am Soc Echocardiogr; 1996; 9(5):629-36. PubMed ID: 8887865
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Soria-Juan B; Garcia-Arranz M; Llanos Jiménez L; Aparicio C; Gonzalez A; Mahillo Fernandez I; Riera Del Moral L; Grochowicz L; Andreu EJ; Marin P; Castellanos G; Moraleda JM; García-Hernández AM; Lozano FS; Sanchez-Guijo F; Villarón EM; Parra ML; Yañez RM; de la Cuesta Diaz A; Tejedo JR; Bedoya FJ; Martin F; Miralles M; Del Rio Sola L; Fernández-Santos ME; Ligero JM; Morant F; Hernández-Blasco L; Andreu E; Hmadcha A; Garcia-Olmo D; Soria B
Trials; 2021 Sep; 22(1):595. PubMed ID: 34488845
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
20. New approach in stage 1 surgery for hypoplastic left heart syndrome: preliminary outcomes.
Çelik M; Gökdemir M; Cındık N; Günaydın AÇ; Aygün F; Özkan M
Cardiol Young; 2023 Sep; 33(9):1544-1549. PubMed ID: 36004405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
